Alzheimer's disease

Senators lambast new Alzheimer’s drug’s price but give Janet Woodcock a free pass on the approval decision
Endpoints
Thu, 06/10/21 - 11:44 pm
Senate
Biogen
Alzheimer's disease
Aduhelm
Janet Woodcock
FDA
AdComm exodus: 2nd expert quits over FDA approval of Biogen's Aduhelm
Fierce Biotech
Thu, 06/10/21 - 11:07 am
FDA
Biogen
Alzheimer's disease
Aduhelm
Faced with historic launch, Biogen to ship Alzheimer's drug in 2 weeks as nearly 1K treatment sites stand ready to go
Fierce Pharma
Wed, 06/9/21 - 11:12 am
Biogen
drug launches
Aduhelm
Alzheimer's disease
Biogen Alzheimer's approval could open the door for other similar drugs
BioPharma Dive
Wed, 06/9/21 - 11:11 am
Biogen
Alzheimer's disease
drug development
aducanumab
Aduhelm
Confirming benefit of Biogen Alzheimer’s disease drug will take 8 years
MedCity News
Wed, 06/9/21 - 11:01 am
Biogen
FDA
clinical trials
Aduhelm
Alzheimer's disease
Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval
Stat
Tue, 06/8/21 - 09:56 pm
Biogen
Aduhelm
Alzheimer's disease
FDA
Biogen Sinks Despite Raft of Analyst Upgrades
Motley Fool
Tue, 06/8/21 - 09:43 pm
Biogen
Aduhelm
aducanumab
Alzheimer's disease
Ready, set, prescribe? Doctors detail why they'll deploy Biogen's new Alzheimer's drug—or not
Fierce Pharma
Tue, 06/8/21 - 12:31 pm
Biogen
Aduhelm
aducanumab
physicians
Alzheimer's disease
Aducanumab approval: ‘We anticipate demand will be high’, says Alzheimer’s Association
Biopharma Reporter
Tue, 06/8/21 - 12:30 pm
Biogen
aducanumab
Alzheimer's disease
Aduhelm
Biogen's 'shockingly broad' Aduhelm label—and $56K price—set up a $10B launch, analysts say
Fierce Pharma
Mon, 06/7/21 - 08:49 pm
Biogen
aducanumab
Aduhelm
FDA
drug pricing
Alzheimer's disease
An extra twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug
Stat
Mon, 06/7/21 - 08:47 pm
Biogen
aducanumab
FDA
Alzheimer's disease
Aduhelm
U.S. FDA approves Biogen Alzheimer's drug
Reuters
Mon, 06/7/21 - 11:17 am
Biogen
aducanumab
Alzheimer's disease
FDA
Biogen shares rise as FDA nears ruling on controversial Alzheimer's drug
Reuters
Mon, 06/7/21 - 11:05 am
Biogen
FDA
aducanumab
Alzheimer's disease
With Action Date Imminent, Biogen's Aducanumab Invokes Hope and Skepticism
BioSpace
Thu, 06/3/21 - 10:59 pm
Biogen
aducanumab
FDA
Alzheimer's disease
Clinical studies for AB Science's all-purpose anti-inflammatory drug grind to a halt as company flags potential risk of heart disease
Endpoints
Tue, 06/1/21 - 11:00 am
AB Science
masitinib
Alzheimer's disease
If the FDA approves Biogen’s Alzheimer’s treatment, I won’t prescribe it
Stat
Mon, 05/31/21 - 06:56 pm
physicians
Biogen
aducanumab
Alzheimer's disease
FDA
'A hugely consequential decision:' How Biogen's Alzheimer's drug came to face the FDA
BioPharma Dive
Thu, 05/27/21 - 11:52 pm
Biogen
FDA
aducanumab
Alzheimer's disease
Alzheimer's patients face several hurdles if Biogen's Alzheimer's drug is OK'd
Beckers Hospital Review
Wed, 05/26/21 - 11:18 am
Biogen
Alzheimer's disease
aducanumab
FDA
Lilly leads the big pharma pack on pipeline value
EP Vantage
Tue, 05/25/21 - 11:04 am
Eli Lilly
diabetes
Alzheimer's disease
GSK
AbbVie
Annovis rises on Alzheimer’s froth
EP Vantage
Tue, 05/25/21 - 11:02 am
Annovis Bio
Alzheimer's disease
ANVS401

Pages